DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1093921
Title:
Dual PET/Fluorescence Imaging of Glioma with an MMP-14-Activatable Peptide Probe
Report Date:
2019-09-01
Abstract:
The purpose of the project is to develop and test, in preclinical models, a sensitive, specific imaging peptide probe to distinguish GBM tissue from healthy tissue. The novel imaging probe targets a cell-surface marker, matrix metalloproteinase14 (MMP-14) that is expressed to a much greater degree in GBM cells than in healthy cells. Upon binding to MMP-14, a dual modality fluorescent tag is activated. This tag is detectable by positron emission tomography (PET) for pre-operative tumor assessment, and by near infrared fluorescence (NIRF) imaging for real-time surgical guidance in distinguishing tumor cells from healthy cells. Results from the project indicate that GBM cells with MMP-14 activity showed activation and retention of NIRF signal from the cleaved peptide probes. Resected mouse brains with patient derived xenograft (PDX) GBM tumors showed tumor-to-background NIRF ratios of 7.6-11.1 at 4 h after i.v. injection of the peptides. PET images showed localization of activity in orthotopic PDX tumors after i.v. injection of radiolabeled peptide probes; uptake of the radiolabeled probes in tumors was significantly reduced (p<0.05) by blocking with the non-labeled peptide. PET and NIRF signals correlated linearly in the orthotopic PDX tumors. Immunohistochemistry showed co-localization of MMP-14 expression and NIRF signal in the resected tumors.
Document Type:
Conference:
Journal:
Pages:
74
File Size:
2.05MB
W81XWH-18-1-0160
(W81XWH1810160);
Contracts:
Grants:
Distribution Statement:
Approved For Public Release
